Joan Miller, a leader in ophthalmology at Harvard Medical School, has transformed the treatment of age-related macular degeneration (AMD) through her innovative research. Funded by the National Institutes of Health, her approach involved adapting cancer therapies for retinal diseases, particularly by using photodynamic therapy. This method, which employs a special dye and laser treatment, represents a significant advancement in treating wet macular degeneration, a leading cause of vision loss for those over 50. Her work showcases the innovative spirit prevalent among retinal surgeons and highlights Miller's contributions to the field.
Miller explains, "It turns out, particularly where abnormal blood vessels develop in these retinal diseases like wet macular degeneration, that the drivers are very similar to what happens in cancer."
Miller emphasizes, "We’re willing to try new surgical techniques; we’re always trying to push the envelope and the technology. It’s just a very innovative specialty."
Collection
[
|
...
]